Every day skin cell renewal is supported with Aramore's hero product, the NAD+ Cell Energizing Treatment, and the transformative results it provides speaks for itself. Using the hydrating, clinically proven treatment, the company ran an eight-week independent clinical human trial on 29 women ages 44 to 61, and findings showed that 100% of participants saw significant improvement across metrics of skin aging, including skin hydration; radiance and brightness; skin texture and smoothness; skin tone; overall healthy appearance of skin; skin homogeneity; dark spot intensity reduction; and hyperpigmentation reduction.
The NAD+ Cell Energizing Treatment is one key piece of The NAD+ Trio, alongside the deeply moisturizing NAD+ Cell Restoration Cream and the NAD+ Renewing Eye Cream.
Skin Cell Renewal Treaments
Aramore's NAD+ Cell Energizing Treatment Enhances Firmness & Tone
Trend Themes
-
Nad+ Topicalization — The translation of NAD+ molecules into stable, skin-penetrating topical formats creates potential for clinically measurable anti-aging products that converge cosmeceuticals with cellular bioenergetics.
-
Evidence-based Cosmetic Claims — Independent, human clinical trials producing quantifiable multi-metric improvements enable a new class of trust-driven brands that differentiate through verified efficacy rather than marketing alone.
-
Multi-product Treatment Systems — Bundled regimens like targeted trios that combine energizing serums with restoration creams open avenues for platform-based subscription models centered on staged cellular repair and maintenance.
Industry Implications
-
Skincare and Cosmetics — Formulation houses and brands stand to be reshaped by demand for bioactive ingredient stabilization and delivery systems that produce lab-validated skin rejuvenation outcomes.
-
Clinical Dermatology — Specialist clinics could pivot toward offering protocolized NAD+-based therapies that blur lines between medical treatments and high-efficacy aesthetic services.
-
Longevity Biotech — Companies working on cellular metabolism and NAD+ biology may expand into consumer-facing topical therapeutics that translate systemic longevity science into localized skin interventions.